Terms: = Gastric cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Clinical Outcome
35 results:
1. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
[No Abstract] [Full Text] [Related]
2. Effects of MSCT enhanced scan image diagnosis on clinical outcome of patients after radical gastrectomy and its influence on misdiagnosis rate.
Yang D; Zhou Y; Peng Z; Ou N
J BUON; 2021; 26(4):1479-1484. PubMed ID: 34565007
[TBL] [Abstract] [Full Text] [Related]
3. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic effect of different etiologies in patients with gastric cardia cancer.
Kim YJ; Chung WC; Cho IH; Kim J; Kim S
Medicine (Baltimore); 2019 Dec; 98(50):e18397. PubMed ID: 31852158
[TBL] [Abstract] [Full Text] [Related]
5. Olaparib in the therapy of advanced ovarian cancer: first real world experiences in safety and efficacy from China.
Ni J; Cheng X; Zhou R; Xu X; Guo W; Chen X
J Ovarian Res; 2019 Nov; 12(1):117. PubMed ID: 31775908
[TBL] [Abstract] [Full Text] [Related]
6. Gene expression profiles for a prognostic immunoscore in gastric cancer.
Zeng D; Zhou R; Yu Y; Luo Y; Zhang J; Sun H; Bin J; Liao Y; Rao J; Zhang Y; Liao W
Br J Surg; 2018 Sep; 105(10):1338-1348. PubMed ID: 29691839
[TBL] [Abstract] [Full Text] [Related]
7. Gastrointestinal Stromal Tumors: A Clinicopathological and Immunohistochemical Study of 65 Cases.
Tepeoğlu M; Özgün G; Tunca MZ; Tezcaner T; Özdemir BH
Turk Patoloji Derg; 2018; 34(3):207-214. PubMed ID: 29630088
[TBL] [Abstract] [Full Text] [Related]
8. clinical outcome after endoscopic submucosal dissection for early gastric cancer of absolute and expanded indication.
Kim JS; Kang SH; Moon HS; Lee ES; Kim SH; Sung JK; Lee BS; Jeong HY
Medicine (Baltimore); 2017 Apr; 96(17):e6710. PubMed ID: 28445280
[TBL] [Abstract] [Full Text] [Related]
9. Dynamic tracing for epidermal growth factor receptor mutations in urinary circulating DNA in gastric cancer patients.
Shi XQ; Xue WH; Zhao SF; Zhang XJ; Sun W
Tumour Biol; 2017 Feb; 39(2):1010428317691681. PubMed ID: 28222666
[TBL] [Abstract] [Full Text] [Related]
10. Extent of lymph node dissection for adenocarcinoma of the stomach.
Mocellin S; McCulloch P; Kazi H; Gama-Rodrigues JJ; Yuan Y; Nitti D
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001964. PubMed ID: 26267122
[TBL] [Abstract] [Full Text] [Related]
11. clinical outcome of lower esophageal sphincter- and vagus-nerve-preserving partial cardiectomy for early gastric cancer of the subcardia.
Matsumoto H; Murakami H; Kubota H; Higashida M; Nakamura M; Hirai T
Gastric Cancer; 2015 Jul; 18(3):669-74. PubMed ID: 24906556
[TBL] [Abstract] [Full Text] [Related]
12. [Clinicopathological characteristics and prognostic analysis of 92 cases with primary gastrointestinal diffuse large B-cell lymphoma].
Feng J; Wan W; Wan W; Wang J; Jing H; Wang J; Zhao W; Liu Y; Ke X
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):288-94. PubMed ID: 24759013
[TBL] [Abstract] [Full Text] [Related]
13. Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.
Gu D; Du M; Tang C; Chu H; Xu Z; Huo X; Gong W; Tang Y; Zhou J; Tong N; Xu Y; Zhang Z; Wang M; Chen J
Environ Mol Mutagen; 2014 Jun; 55(5):421-7. PubMed ID: 24535941
[TBL] [Abstract] [Full Text] [Related]
14. Association of polymorphisms in virulence factor of Helicobacter pylori and gastroduodenal diseases in South Korea.
Kim JY; Kim N; Nam RH; Suh JH; Chang H; Lee JW; Kim YS; Kim JM; Choi JW; Park JG; Lee YS; Lee DH; Jung HC
J Gastroenterol Hepatol; 2014 May; 29(5):984-91. PubMed ID: 24372834
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological and molecular aspects of foregut gastrointestinal stromal tumours.
Chen J; Gundara JS; Haddad R; Schiavone V; Meldrum C; Samra JS; Gill AJ; Hugh TJ
ANZ J Surg; 2014; 84(1-2):52-8. PubMed ID: 23171083
[TBL] [Abstract] [Full Text] [Related]
16. clinical outcome of biliary drainage for obstructive jaundice caused by colorectal and gastric cancers.
Kasuga A; Ishii H; Ozaka M; Matsusaka S; Chin K; Mizunuma N; Yukisawa S; Matsueda K; Furuse J
Jpn J Clin Oncol; 2012 Dec; 42(12):1161-7. PubMed ID: 23072841
[TBL] [Abstract] [Full Text] [Related]
17. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.
Peng L; Zhan P; Zhou Y; Fang W; Zhao P; Zheng Y; Xu N
Mol Biol Rep; 2012 Oct; 39(10):9473-84. PubMed ID: 22729879
[TBL] [Abstract] [Full Text] [Related]
19. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial.
Van Cutsem E; de Haas S; Kang YK; Ohtsu A; Tebbutt NC; Ming Xu J; Peng Yong W; Langer B; Delmar P; Scherer SJ; Shah MA
J Clin Oncol; 2012 Jun; 30(17):2119-27. PubMed ID: 22565005
[TBL] [Abstract] [Full Text] [Related]
20. A newly designed big cup nitinol stent for gastric outlet obstruction.
Shi D; Liao SH; Geng JP
World J Gastroenterol; 2010 Sep; 16(33):4206-9. PubMed ID: 20806440
[TBL] [Abstract] [Full Text] [Related]
[Next]
